#clinical study software
Explore tagged Tumblr posts
Text
Empowering Sponsors with Compliant Data Collection and Integrity for a Variety of Clinical Studies | Jeeva Trials
Traditional clinical guidelines, and stand-alone patient study and care pathways are proven to be increasingly inadequate, especially in a post-pandemic world with low clinical adherence, disrupted workflows, and stay-at-home orders. Disrupted workflows means more time required to complete a study, fatigue of the research team, and wastage of resources.
Researchers and study teams are increasingly adopting eClinical cloud trial tools that are designed to augment researchers, study teams and clinicians to augment their complex decision-making processes with targeted clinical knowledge, patient information and computerized clinical workflows. It directly improves the quality of clinical documentation. AI technologies provide the tool capabilities for drawing insights into data beyond what humans can. CROs (Contract Research Organizations) evaluate clinical study tools largely based on speed, flexibility and cost-efficiency. However, amidst these concerns, data integrity is not to be understated or taken for granted. Data integrity is not only important for a study, it needs to be addressed throughout the product life cycle across Good Clinical Practices (GCP), Good Laboratory Practice (GLP), Good Manufacturing Practice (GMP), and other Good Practice (GxP) areas.
Data integrity is critical for studies
Good risk mitigation and management is essential to data integrity as multiple points of risk exist throughout data recording, storage, transfer, reporting and other stages of data lifecycle during a study trial. It is achieved by making data traceable throughout audit trails. Transparency is demonstrated with a chain of custody from data origin to its analysis. Without data integrity, it is not possible to regenerate a previous clinical trial result reliably. Data integrity cannot be validated by point-to-point interfaces of individual systems alone, it requires a more holistic approach towards validation and quality management as these systems need to work together across corporate borders and multi-site systems.
Quality of data can affect the quality of decision support because if data collection is not standardized, the study trial data is effectively corrupted and increases the risk of failure during the submission procedure for approval by Food and Drug Administration (FDA), Medicines and Healthcare Products Regulatory Agency (MHRA) and other regulators. Regulators in the US and across the world continue to stress the criticality of data integrity in clinical trials.
Points to consider while choosing an eClinical study solution:
A good system should not delete or obscure previously-recorded audit trail information and prevent modification by the user.
It should record complete audit trail records including identification of the data element that was changed, who authorized the change and implemented them.
It should provide early visibility to reliable data to quickly make sound decisions and bring life-enhancing treatments to life.
Cyber security is a mission-critical consideration for electronic clinical outcomes assessment (eCOA) risk management for any eClinical solution.
Regulatory-minded study teams will have data integrity plans in place as regulators can raise questions about data collection compliance, warranting rescue action. By utilizing the Jeeva Informatics eClinical cloud, study teams can have regulation-compliant risk mitigation with complete transparency, traceability, and documentation. Jeeva is a flexible bring your own device (BYOD), SaaS (Software as a Service) solution that is designed to maintain data integrity with features and protocols that fit the specific trial protocol, ensuring reliability and authenticity of the study data by adhering to the most current compliance regulations in force.
Shortening the Distance from Study Data to Action
Jeeva’s highly scalable SaaS architecture provides a cost-effective approach to support trials for multiple studies, phases and therapeutic areas. Its intuitive interface eliminates the multi-step process to navigate reports and shortens the distance from study data to action. In clinical research, data integrity and reliability of trial results are paramount. The value of a comprehensive and compliant eClinical tool is absolute. Data integrity continues to be a major theme across inspection results. The collaborative technology used in Jeeva automates high-value clinical trials recruitment and retention tasks and provides insightful retrieval of information. Adherence to the International Council on Harmonization (ICH) GCP is a core tenet for data integrity at Jeeva.
Leading research organizations have consistently been using Jeeva for compliant and adaptive research with access to immediately actionable patient data. It provides researchers personalized clinical study documentation across solutions, platforms and devices, anytime and anywhere, regardless of physical location.
Enabling Clinical Research at Scale
A failed trial not only sinks investment into the early stages of the trial itself but also results in dissatisfied sponsor clients and impacts your long and fruitful business relationship with them. Jeeva is designed to support the conduct of clinical trials utilizing validated functionality and processes. The modular software enables clinical research at scale and saves more than 70% time and logistic burden on the study teams. Utilizing the platform-agnostic software with advanced features like bi-directional communications, scheduling and touch-less electronic informed consent, investigators can rapidly enroll participants in the study, and investigators can safely review the study material remotely and conveniently from their own mobile device.
Complying with the Current Regulations
Jeeva Trials follows a human-centric approach with a deep understanding of the perspectives and requirements of various stakeholders including regulatory compliance specialists, IT security and privacy professionals, auditors and coordinators. The burden of ensuring regulatory compliance of technology solutions, GDPR (General Data Protection Regulation), Institutional Review Boards (IRBs), human subjects protection guidelines, GCP (Good Clinical Practice) guidelines by ICH (International Council of Harmonization) of Technical Requirements for Pharmaceuticals for Human use, and other regional guidelines lies with the study sponsor. Jeeva adheres to the current federal, state, and international regulations or guidelines for conducting clinical trials using electronic patient data such as the FDA 21 CFR (Code of Federal Regulations) Part 11, SOC 2 (System Organ Classes), Amazon Well (AWS) Architected Framework Review, AWS Foundational Technical Review, GDPR privacy policies, and others. Avoid having to validate multiple a la carte tools as you can now achieve the same goal with a single all-in-one integrated SaaS platform.
Saving on Costs of Failed Trials
It takes on average 10-15 years and USD 1.5-2.0 billion to bring a new drug to the market. Approximately half of this expenditure covers testing, preclinical compound discovery and regulatory processes. The high failure rate of clinical trials due to regulatory issues, patient non-adherence, low retention and high drop-offs during long-term studies is a major stumbling block in drug development. Less than one-third of all Phase II compounds advance to Phase III, with more than one third of all Phase III compounds failing to advance to approval. The most complex Phase III trials carry nearly 60% of the overall trial costs, resulting loss per failed clinical trial to the order of 0.8-1.4 billion USD.
Flexible Platform to Accelerate Patient Recruitment
Study build delays cause timelines to drag on, as such CROs face not only dissatisfied sponsor clients but they could lose a fruitful business relationship. There are major regulatory implications as well, as unverified, disintegrated and dubious data quality can land organizations in court. Jeeva Informatics Solutions is designed to reduce timelines for study startup and participants by up to more than 50%, while complying with data integrity regulations of the federal and state governments. Jeeva makes it easy for longitudinal cohort studies to collect validated data from participants in real-world settings over extended periods of time. The flexible platform accelerates patient recruitment and retention, and enables long-term engagement for 5, 10, or 15-year follow-up studies for long-term trials, such as cell and gene therapy.
Affordable subscription-based pricing of Jeeva makes it easier for the study teams to plan budgets with predictable expenses. The modular SaaS subscription model helps clinical researchers, Contract Research Organizations (CROs), and sponsors manage a clinical study’s annual budget on a simple, per participant basis.
#eclinical cloud#clinical trial cloud software#eclinical platform#mobile eclinical#clinical trial recruitment challenges#decentralized clinical trials software#software for clinical trials#clinical research software#clinical study software#software used in clinical research#clinical trials software#software used in clinical trials#clinical solutions research platforms#accelerating patient recruitment#patient retention in clinical trials
1 note
·
View note
Text
What is IRT and How Does it Impact Clinical Trials? — Octalsoft
An IRT system is also known by several other names, including IVRS, IWRS, IXRS, and RTSM, but regardless of its name, the system provides a comprehensive set of capabilities for managing patient enrollment and drug supply operations throughout the clinical trial lifecycle. IRT, or Interactive Response Technology, is a technology that automates clinical trial supply management, randomization, and analytics. IRT clinical trials guarantee that participants receive the appropriate therapy at the appropriate time, allow for improved drug supply logistics tracking, and allow researchers to collect real-time data from people during the trial.
An IRT clinical trial software can assist in enhancing productivity, decrease risks, and reduce costs in clinical investigations by providing different automation. But there’s more. Read on for the top 5 areas of impact of an IRT deployed to Clinical trials.
The Advantages of Deploying IRT to Clinical Trials
Patient Enrollment, Randomization, and Blind Protection — As compared to manual techniques, using the IRT to manage enrollment and/or randomization automates the process and eliminates human error. To preserve research blinding, the system enables for complicated protocol enrollment and randomization design and rigorously controls sensitive information such as treatment arm and drug treatment assignments.
Patient Randomization
The IRT will randomly allocate patients to treatment arms in a methodical manner. There are various commonly utilized approaches, including central, subject-stratified, and/or location-stratified randomization systems. The IRT will allocate the individual to the appropriate treatment arm during the randomization visit based on the programmed randomization process. In most cases, IRT clinical trial solutions will also provide the individual with the medicine kit that corresponds to the randomized treatment arm.
To properly grasp how effectively an IRT randomizes patients in a double-blind experiment, consider how it was done before IRT was available. When an IRT is not used, each patient on the randomization list is assigned a treatment type and matching kit number. The number is sealed in an envelope with a sequential number on it. A batch of envelopes and the related kits are sent to the experimental site, where envelopes are selected in order. The patient is subsequently given the appropriate kit.
While this approach works pretty well on a small scale, it is sluggish and only works with simple randomization patterns. Also, it is susceptible to human error.
IRT manages randomization in an automated and centralized manner. It can allow complicated classification and randomization designs that manual randomization cannot. Because randomization occurs without human interaction, it decreases human error. Furthermore, as with other parts of study management, the data is saved in the system for simple tracking. The automated randomization and medication assignment method avoids the need to maintain paper envelopes or cards at the location, where unblinded information might be compromised.
2. Study Blinding
The IRT clinical study plays a crucial role in preventing unblinded trial data from being shared improperly. Maintaining the blind in blinded trials is critical to the trial’s integrity since it prevents bias in how patients are treated. Overall, the IRT functions almost as a force field, shielding unblinded information, such as treatment arm and medicine kind, from individuals who should not have access to it. Access to system functions is limited by user privileges, so only users who should have access to unblinded data in the IRT may view it.
The ideal IRT is frequently equipped with emergency unblinding capabilities. This can be configured such that Principal Investigators can unblind patients at their locations in the event of an emergency. When the site has an emergency code breach, the system quickly alerts the research team. Often, the patient who was unblinded by the site is instantly removed from the research, prohibiting the IRT from assigning any additional drugs. The IRT can also provide patients access to the Medical Safety team, which can unblind any patient at any location without interfering with their continued participation in the trial.
3. Supply Management
Individual kits in the depot and on-site are not labeled for specific patients. Instead, patients are given kits when they come for their appointments. As a result, shipments to locations only include enough stock to fulfill patient demand for a set period of time and resupplies are triggered when stockpiles reach a predetermined level. Because products are only assigned to patients when they come in for visits, this procedure increases medicine availability at the location while minimizing drug waste. Because the IRT knows what patients are at each location, their treatment arms, and the visit schedule, it can adjust the supply delivered to each site.
Controlling costs requires developing and maintaining an accurate prediction of product demand over the length of a clinical study. The IRT gives Supply Chain Managers real-time updates on patient registration and product inventories across the supply chain. This helps with budgeting, saves waste from hoarding goods, avoids stock-outs, and decreases the need for emergency steps to replace expired pharmaceuticals.
An interactive response technology in clinical trials may also keep track of product expiry dates to ensure that the patient has enough time to take the medication before it expires. It can also notify study managers when expirations are approaching. Because of their limited shelf life, medications that must be actively controlled require this notice. Probably most importantly, an IRT provides supply managers with a comprehensive picture of available supplies at the main depot, subsidiary depot, and site levels. As a result, they may change their inventory and distribution strategies to fit the current trial circumstances.
4. Inventory Management
The IRT provides a number of capabilities to manage the supply chain in a trial, from the moment supplies are packaged and distributed at the depot to medicine assignment, drug returns, and destruction. When goods are physically packaged and made available in the system, transportation to another depot or location is initiated and tracked. When the Sponsor activates an IRT site, the system sends a request to the depot for an initial supply of medicine. The depot fulfills the order and delivers it to the spot. When an order arrives at the site, personnel confirms receipt in the IRT and makes the medications accessible for patient assignment.
Patients who visit the site are given a medicine kit from the center’s inventory. An algorithm within the system is constantly checking the inventory at each station. If the inventory falls below a certain threshold, the supply engine will submit a request to the depot to provide a replenishment. Shipments are made through this closed-loop procedure to accommodate newly enrolled patients, following visits, and any needed replacement stock. Another key feature of the IRT that is sometimes neglected is the ease with which drug accountability, returns, and destruction may be accomplished. In many research, this procedure is still done manually, which is difficult and time-consuming. Sites can save time, enhance efficiency, and minimize data by switching the process electronically via the IRT.
5. Patient Tracking and Reporting
All patient and supply data contained in the IRT database is easily accessible via reports and data lookups. This gives the clinical and drug management teams real-time access to data, study parameters, and alarms. This facilitates reviewing the research as it goes and making any required changes to things like enrollment or site inventory settings to match the exact condition of the trial at any given moment.
In Summation
An IRT, in essence, enhances trial efficiency and the quality of accessible information during a trial. Sponsors, CROs, and investigators are conducting more sophisticated studies than ever before with fewer employees and fewer resources thanks to IRT systems.
An IRT solution enables sponsors to create and use the functionality they require while eliminating extraneous complications. This method aids in reducing the time it takes to launch a clinical study, allowing much-needed treatments to reach patients faster than ever before. When time is of importance, such as in the event of a worldwide pandemic, IRT devices can really be game changers by assisting effective treatments to demonstrate benefits as quickly as feasible and at a reduced cost.
Ultimately, the adoption of an IRT empowers researchers, sponsors, and study personnel with the tools and capabilities needed to effectively manage and monitor a clinical trial, leading to reliable outcomes, improved decision-making, and the advancement of evidence-based medicine. But not every IRT matches the standards of a modern clinical trial. What you need is a vetted partner like Octalsoft that can deploy a highly efficient IRT/IWRS that matches and exceeds benchmarks. Want to know more about how Octalsoft’s IRT/IWRS can turbocharge the productivity of personnel and boost the effectiveness of your clinical trial? Book a Demo with us NOW! With Octalsoft’s systems, sponsors win, investigators win and, most importantly, patients win.
#irt clinical trials#interactive response technology clinical trials#irt clinical study#irt clinical trial software#irt clinical trial solutions
0 notes
Text
On Saturday, an Associated Press investigation revealed that OpenAI's Whisper transcription tool creates fabricated text in medical and business settings despite warnings against such use. The AP interviewed more than 12 software engineers, developers, and researchers who found the model regularly invents text that speakers never said, a phenomenon often called a “confabulation” or “hallucination” in the AI field.
Upon its release in 2022, OpenAI claimed that Whisper approached “human level robustness” in audio transcription accuracy. However, a University of Michigan researcher told the AP that Whisper created false text in 80 percent of public meeting transcripts examined. Another developer, unnamed in the AP report, claimed to have found invented content in almost all of his 26,000 test transcriptions.
The fabrications pose particular risks in health care settings. Despite OpenAI’s warnings against using Whisper for “high-risk domains,” over 30,000 medical workers now use Whisper-based tools to transcribe patient visits, according to the AP report. The Mankato Clinic in Minnesota and Children’s Hospital Los Angeles are among 40 health systems using a Whisper-powered AI copilot service from medical tech company Nabla that is fine-tuned on medical terminology.
Nabla acknowledges that Whisper can confabulate, but it also reportedly erases original audio recordings “for data safety reasons.” This could cause additional issues, since doctors cannot verify accuracy against the source material. And deaf patients may be highly impacted by mistaken transcripts since they would have no way to know if medical transcript audio is accurate or not.
The potential problems with Whisper extend beyond health care. Researchers from Cornell University and the University of Virginia studied thousands of audio samples and found Whisper adding nonexistent violent content and racial commentary to neutral speech. They found that 1 percent of samples included “entire hallucinated phrases or sentences which did not exist in any form in the underlying audio” and that 38 percent of those included “explicit harms such as perpetuating violence, making up inaccurate associations, or implying false authority.”
In one case from the study cited by AP, when a speaker described “two other girls and one lady,” Whisper added fictional text specifying that they “were Black.” In another, the audio said, “He, the boy, was going to, I’m not sure exactly, take the umbrella.” Whisper transcribed it to, “He took a big piece of a cross, a teeny, small piece … I’m sure he didn’t have a terror knife so he killed a number of people.”
An OpenAI spokesperson told the AP that the company appreciates the researchers’ findings and that it actively studies how to reduce fabrications and incorporates feedback in updates to the model.
Why Whisper Confabulates
The key to Whisper’s unsuitability in high-risk domains comes from its propensity to sometimes confabulate, or plausibly make up, inaccurate outputs. The AP report says, "Researchers aren’t certain why Whisper and similar tools hallucinate," but that isn't true. We know exactly why Transformer-based AI models like Whisper behave this way.
Whisper is based on technology that is designed to predict the next most likely token (chunk of data) that should appear after a sequence of tokens provided by a user. In the case of ChatGPT, the input tokens come in the form of a text prompt. In the case of Whisper, the input is tokenized audio data.
The transcription output from Whisper is a prediction of what is most likely, not what is most accurate. Accuracy in Transformer-based outputs is typically proportional to the presence of relevant accurate data in the training dataset, but it is never guaranteed. If there is ever a case where there isn't enough contextual information in its neural network for Whisper to make an accurate prediction about how to transcribe a particular segment of audio, the model will fall back on what it “knows” about the relationships between sounds and words it has learned from its training data.
According to OpenAI in 2022, Whisper learned those statistical relationships from “680,000 hours of multilingual and multitask supervised data collected from the web.” But we now know a little more about the source. Given Whisper's well-known tendency to produce certain outputs like "thank you for watching," "like and subscribe," or "drop a comment in the section below" when provided silent or garbled inputs, it's likely that OpenAI trained Whisper on thousands of hours of captioned audio scraped from YouTube videos. (The researchers needed audio paired with existing captions to train the model.)
There's also a phenomenon called “overfitting” in AI models where information (in this case, text found in audio transcriptions) encountered more frequently in the training data is more likely to be reproduced in an output. In cases where Whisper encounters poor-quality audio in medical notes, the AI model will produce what its neural network predicts is the most likely output, even if it is incorrect. And the most likely output for any given YouTube video, since so many people say it, is “thanks for watching.”
In other cases, Whisper seems to draw on the context of the conversation to fill in what should come next, which can lead to problems because its training data could include racist commentary or inaccurate medical information. For example, if many examples of training data featured speakers saying the phrase “crimes by Black criminals,” when Whisper encounters a “crimes by [garbled audio] criminals” audio sample, it will be more likely to fill in the transcription with “Black."
In the original Whisper model card, OpenAI researchers wrote about this very phenomenon: "Because the models are trained in a weakly supervised manner using large-scale noisy data, the predictions may include texts that are not actually spoken in the audio input (i.e. hallucination). We hypothesize that this happens because, given their general knowledge of language, the models combine trying to predict the next word in audio with trying to transcribe the audio itself."
So in that sense, Whisper "knows" something about the content of what is being said and keeps track of the context of the conversation, which can lead to issues like the one where Whisper identified two women as being Black even though that information was not contained in the original audio. Theoretically, this erroneous scenario could be reduced by using a second AI model trained to pick out areas of confusing audio where the Whisper model is likely to confabulate and flag the transcript in that location, so a human could manually check those instances for accuracy later.
Clearly, OpenAI's advice not to use Whisper in high-risk domains, such as critical medical records, was a good one. But health care companies are constantly driven by a need to decrease costs by using seemingly "good enough" AI tools—as we've seen with Epic Systems using GPT-4 for medical records and UnitedHealth using a flawed AI model for insurance decisions. It's entirely possible that people are already suffering negative outcomes due to AI mistakes, and fixing them will likely involve some sort of regulation and certification of AI tools used in the medical field.
87 notes
·
View notes
Text
Pain emerges as dominant symptom in long Covid, UCL study reveals - Published Aug 28, 2024
Pain may be the most prevalent and severe symptom reported by individuals with long Covid, according to a new study led by UCL (University College London) researchers.
The study, published in JRSM Open, analysed data from over 1,000 people in England and Wales who logged their symptoms on an app between November 2020 and March 2022.
Pain, including headache, joint pain and stomach pain, was the most common symptom, reported by 26.5% of participants.
The other most common symptoms were neuropsychological issues such as anxiety and depression (18.4%), fatigue (14.3%), and dyspnoea (shortness of breath) (7.4%). The analysis found that the intensity of symptoms, particularly pain, increased by 3.3% on average each month since initial registration.
The study also examined the impact of demographic factors on the severity of symptoms, revealing significant disparities among different groups. Older individuals were found to experience much higher symptom intensity, with those aged 68-77 reporting 32.8% more severe symptoms, and those aged 78-87 experiencing an 86% increase in symptom intensity compared to the 18-27 age group.
Gender differences were also pronounced, with women reporting 9.2% more intense symptoms, including pain, than men. Ethnicity further influenced symptom severity, as non-white individuals with long Covid reported 23.5% more intense symptoms, including pain, compared to white individuals.
The study also explored the relationship between education levels and symptom severity. Individuals with higher education qualifications (NVQ level 3, 4, and 5 – equivalent to A-levels or higher education) experienced significantly less severe symptoms, including pain, with reductions of 27.7%, 62.8%, and 44.7% for NVQ levels 3, 4 and 5 respectively, compared to those with lower education levels (NVQ level 1-2 – equivalent to GCSEs).
Socioeconomic status, as measured by the Index of Multiple Deprivation (IMD), also influenced symptom intensity. Participants from less deprived areas reported less intense symptoms than those from the most deprived areas. However, the number of symptoms did not significantly vary with socioeconomic status, suggesting that while deprivation may exacerbate symptom intensity, it does not necessarily lead to a broader range of symptoms.
Our study highlights pain as a predominant self-reported symptom in long Covid, but it also shows how demographic factors appear to play a significant role in symptom severity.
With ongoing occurrences of Covid-19 (e.g., LB.1, or D-FLiRT variants), the potential for more long Covid cases remains a pressing concern. Our findings can help shape targeted interventions and support strategies for those most at risk."
-Dr. David Sunkersing, Lead Author, UCL Institute of Health Informatics
In the paper, the researchers called for sustained support for long Covid clinics and the development of treatment strategies that prioritize pain management, alongside other prevalent symptoms like neuropsychological issues and fatigue.
Given the significant impact of demographic factors on symptom severity, the study underscored the need for healthcare policies that addressed these disparities, ensuring equitable care for all individuals affected by long Covid, the researchers said.
Study limitations included a lack of information on other health conditions participants may have had and a lack of information about health history. The researchers cautioned that the study may have excluded individuals with very severe Covid and those facing technological or socioeconomic barriers in accessing a smartphone app.
The study was led by the UCL Institute of Health Informatics and the Department of Primary Care and Population Health at UCL in collaboration with the software developer, Living With Ltd.
Source: University College London
Journal reference: Sunkersing, D., et al. (2024) Long COVID symptoms and demographic associations: A retrospective case series study using healthcare application data. Materials Today. doi.org/10.1177/20542704241274292. journals.sagepub.com/doi/10.1177/20542704241274292
#covid#mask up#pandemic#covid 19#wear a mask#coronavirus#sars cov 2#public health#still coviding#wear a respirator#long covid
15 notes
·
View notes
Note
Okay I need to know, out of all the Thomas Levin content you watched, which ones were worth watching?! I kind of want to check out Alfa
Ooh that’s a good question - I will add the disclaimer that I’ve absolutely not watched 100% of any of these shows (except for Alex Rider, which I’ve somehow watched 300% of,) I’m mostly just hunting for Levin scenes that could be interesting seen through the lens of Yassen - but there’s definitely some that have drawn me in more than others, there’s also a substantial amount I’ve only been able to find only in Danish, with Danish subs.
His episode of Unit One is pretty fun, and thanks to Mads Mikkelson fans, it’s fairly easy to find links on reddit to the episodes that will also have subtitle files you can important into a video player.
His episode of Taxa from when he was like 20 is on drtv, full Danish but is still quite fun to skip through to just see his scenes, it’s fairly easy to pick up on the context clues to follow the story.
His scenes in ‘Those who kill’ and ‘Strike Back’ are brilliant, but the shows are really hard to find and I had to buy them, so tricky. I might be able to isolate his scenes and share them, but not totally sure, my usual screen recording software doesn’t have sound .
These next ones were easier to find on streaming, at least in the uk, on Netflix or channel 4 has a lot of them -
Smother, bit meh, might give it a miss, but him being a dad to a teenager is quite cute.
Borgen can be interesting, very heavy on the politics - I didn’t dwell on this one much, as a lot of his scenes are either presenting the news, or in meetings discussing the news, but his character is an little shit in a fairly fun way.
Stockholm Requiem I got more into, and he’s a pretty central character who gets up to some interesting shit - it is *dark* however, and fairly heavy on the child murder.
Seaside hotel (gifs upcoming) is quite a fun show, though there’s some tonal disparity there, bc it’s basically a lighthearted show about people on holiday on the 1930s-40s, and he’s playing a Jewish man fleeing a Nazi work camp, but I enjoyed this show. He has a sweet little romance.
Baby fever is a really fun show - it’s a comedy about a woman who works at a fertility clinic and breaks into the sperm bank Levin manages when drunk and inseminates herself - there’s supposed to be another season soon (today, maybe?) which he’s also in, and I’ll definitely be checking out for gif making potential
Alfa/Grow is good - it’s another fairly dark crime drama that’s got multiple storylines converging together around the drug trade in Copenhagen, his story line is as a member of this secretive police unit acting as a mentor to one of the main characters, whose father was involved in the drug trade but has become a cop. An interesting role for him - he’s the dad of a teenager again, which I enjoy, and is a bit of an ass.
+I will say in my Levin studies, I’ve definitely noticed some typical archetypes he tends to fit into - full blown criminals who can and will murder you, assholes who are really good at their jobs (Yassen fits into the overlap there 😅) and a few, much rarer, genuinely nice guys trying their best. I might make some kinda Venn diagram to display this crucial data bc I do already have this info in a table, including important subcategories, like ‘beard?’ Or ‘dad?’ Just not totally sure how to present this information 😅😅
17 notes
·
View notes
Text
Understanding Police Recruitment Result Implications for Future Candidates
The recruitment procedure for police officers is vital in retaining law and order in society. Police departments internationally seek devoted individuals who are devoted to serving their groups. With the development of technology, many police departments have streamlined their application techniques, permitting candidates to use online. This manual will provide a top-level view of a way to observe online police recruitment, what the recruitment system includes, and pointers for successful software.
Police Recruitment Result
Understanding Police Recruitment
Police recruitment is the manner by way of which regulation enforcement companies select and lease new officials. This method commonly includes several steps, which include:
Application Submission: Candidates submit their programs, which encompass personal facts, educational history, and work experience.
Preliminary Screening: The branch critiques programs to make sure candidates meet the minimal qualifications, which can also encompass age, education, and physical health requirements.
Written Examination: Candidates can be required to take a written examination to evaluate their cognitive abilities, reasoning abilities, and knowledge of regulation enforcement ideas.
Physical Fitness Assessment: Physical health assessments are carried out to ensure candidates can perform the demanding duties of a police officer.
Background Investigation: A thorough background check is carried out to verify the candidate's history, including criminal data, employment records, and private references.
Interview: Successful applicants are invited for an interview with police branch officials.
Psychological Evaluation: Candidates can also undergo mental checks to ensure they are mentally able to handle the demands of police work.
Medical Examination: A clinical exam ensures candidates meet the health necessities necessary for police work.
Training Academy: Those who skip all of the preceding steps are enrolled in a police training academy.
The Online Application Process
Applying online for a police role can be a convenient way to begin your journey into law enforcement. Here’s a step-by-step guide on the way to apply online for police recruitment:
Research the Department
Before applying, study various police departments to locate one that aligns together with your values and professional dreams. Each department can also have precise necessities and options, which include:
Educational Requirements: Some departments require at least an excessive faculty diploma, whilst others might also select or require a college degree.
Background Checks: Understand the branch's guidelines concerning crook facts and beyond conduct.
Visit the Official Website
Once you've been diagnosed with a police department you want to apply to, go to their respectable website. Most police departments have a committed phase for recruitment that provides information about contemporary openings, application processes, and specific requirements.
Create an Online Account
Most police departments require applicants to create a web account to apply. This account will assist you to:
Fill out and submit your software.
Track the fame of your application.
Access vital documents and forms.
Make sure to apply a legitimate e-mail cope with, as all conversations regarding your utility will in all likelihood be sent there.
Complete the Application Form
Fill out the web application form appropriately. Be prepared to offer:
Personal Information: Name, deal with, date of birth, and make contact with facts.
Education History: Schools attended, levels earned, and relevant certifications.
Employment History: Previous jobs, such as dates of employment, activity titles, and descriptions of duties.
References: Contact information for folks that can vouch to your man or woman and work ethic.
Submit Required Documents
Many police departments require assisting documents to accompany your utility. Common documents can also include:
Resume: A cutting-edge resume detailing your work to revel in and abilities.
Cover Letter: A letter expressing your interest in the function and your qualifications.
Transcripts: Academic transcripts from excessive faculty and any post-secondary training.
Certifications: Any applicable certifications, together with CPR or first aid.
Ensure all files are formatted efficaciously and submitted in the required record formats.
Pay Application Fees (if relevant)
Some police departments charge an application charge. If required, ensure you pay this charge as a part of the software system. Keep a receipt of the transaction to your information.
Review and Submit
Before submitting your application, carefully evaluate all information for accuracy and completeness. Double-check that each one required documents is connected. Once you are confident everything is accurate, put up your utility.
After Submission
Once your application is submitted, the ready sport starts offevolved. Here’s what to expect subsequent:
Confirmation of Application: You will generally receive an affirmation e-mail acknowledging receipt of your software.
Application Review: The department will assess your software to determine in case you meet their minimal qualifications.
Notification of Next Steps: If you skip the initial evaluation, you will be notified approximately the subsequent steps in the recruitment procedure, which may additionally include scheduling assessments and interviews.
Tips for a Successful Application
To enhance your chances of fulfillment, bear in mind the following tips:
Be Honest: Complete your application certainly. Any discrepancies can result in disqualification.
Tailor Your Resume: Customize your resume and cover letter for the unique police department and role.
Prepare for Tests: Study for written exams and exercise bodily health assessments earlier.
Gather References Early: Choose references who understand you nicely and might offer fantastic testimonials approximately your individual and painting's ethic.
Follow Up: If you haven’t heard lower back inside an affordable time frame, don't forget to follow up with the department to inquire about your utility status.
2 notes
·
View notes
Note
Did you ever make an Axis and/or guardner design for if Undertale Yellow characters were in your AU (Sw!Fallenswap)? Also, I think the idea of this swap au Undyne and Kanako actually being buddies and working together unlike how Chujin and Alphys were competitors in UTY (or at least technically/indirectly competitors as they both wanted the royal scientist job) is cute, also I suppose it would make sense for Starlo to not react negatively if you destroy either of the robots like Ceroba would because Starlo probably won't have the same sentiment towards them and probably would value Clover's safety more than a machine.
I don't have one for Axis, didn't really have an idea for him but I did have one for Guardner, I gave Guardner (or in this AU Guard-N.E.R) 3 different bodies, one mobile version, a screen version and a mainframe computer version which changes depending on where you are in Steamworks, in the beginning and a few other areas, it's just the screen hanging from the ceiling or a wall and during the battle portion it's the main computer while other times like when you're getting chased it's the mobile body.
Also, I'm glad you like the idea, even if I didn't put too much thought into it since it isn't completely canon to the AU.
(3 different bodies)
Transcript: I SAID NO FLASH PHOTOGRAPHY.
(Guard-N.E.R and Starlo)
Transcript: if we end up destroying it, promise me not to tell Ceroba, she'll be mad.
To anyone who hasn't seen the previous post regarding this, here's the link to that:
But, what is relevant to know in this, (that may or may not have been mentioned in the orginal post) is...
Kanako and Undyne did get along during their time doing their internship, though they often have creative differences, they still collaborate together effectively.
Starlo doesn't like Guard-N.E.R, because he views the robot as a threat to Clover's wellbeing.
Guard-N.E.R is AI, it's not stated what her purpose really is besides being proof of learning but she is currently being used to protect/maintain the Steamworks.
Follow up dialogue to the above comic and dialogues of what happens if you spare or kill guardner that I don't know where to fit in this post but give useful information on this character are below the cut:
Follow-up dialogue to the mini comic of Kanako and Undyne presenting their creation:
Toriel: Gardener? As in one who tends a garden?
Undyne: no, it's Guard, like as in royal guard and NER which is an acronym for “Neuroelectrical Emulation Robot”
Kanako: It was originally going to be “Brain Emulation Robot” but Guard-Ber didn't sound as good.
Undyne: by using the technology and discoveries we have made in our research on mortal minds ever since we discovered living organisms 570 million years ago and the studies on brains we have made for the past 540 million years, I was able to use the technology one inventor made that transcribes brain functions into computer code and used it to replicate parts of the brain as computer software and hardware.
Kanako: We couldn't mimic EVERYTHING that a brain could do, and if we did we definitely didn't have the materials to do so
Undyne: So to save on material costs, we contacted the Neurology Center inside Hotland’s National Veterinary clinic to give us some insight on how the human brain works and what we don't need to incorporate into the robot as it won't serve any use. For example, we were able to cut out most of the limbic system and the hypothalamus
Kanako: In regards to data training, we have trained it on information of all volumes of Royal Guard HandBooks and Monstarian Law, so it knows every single protocol, code of conduct, law within our government and much more!
Dialogue that plays when you spare GUARD-N.E.R:
Guard-ner: MAYBE YOU ARE NOT SO BAD-
Starlo: *Tarzan Yell*
G-NER: WHAT IS THAT DREADED NOISE?
Starlo, swings into view using some sort of cable as a rope to swing on: EAT THE POWER OF MOMENTUM AND INERTIA!!
Starlo will end up colliding with the computer mainframe GUARD-N.E.R body and knocks it over the platform.
Starlo: Bullseye!! Now, I just need to figure out how to safely (*cable snaps and Starlo falls faceplants*) nevermind...
Dialogue that plays if you kill Guard-N.E.R:
GUARD-N.E.R: *BZIT-* ERROR. ERROR. SYSTEM DAMAGED. SENDING EMERGENCY SOS. PROCESSING. PROCESSING. TELE-COMS DOWN. ATTEMPTING TROUBLESHOOTING. TROUBLESHOOTING. TROUBLESHOOTING UNSUCCESSFUL.
Starlo, busting through guns ablazing: HOLD THOSE HANDS UP OUTLAW, I GOT YOU AT GUN POINT!!
G-N.E.R, lacking hands: CANNOT *BZIT-* PROCESS REQU- SHUTTING DOWN.
Starlo: huh, you already destroyed it, good job! But, cover your ears, I'm going to shoot it a couple times real quick to make sure it's actually destroyed and not playing a trick or something.
Clover: really, or is it your disdain for it
Starlo: Maybe a mix of both.
#undertale#undertale by toby fox#undertale au#UTY#uty#sw!fallenswap#digital art#traditional art#dialouge#ask response#asks#uty guardener#uty starlo#uty clover#uty Kanako#sw!Fallenswap Undyne#au undyne
6 notes
·
View notes
Text
I will now liveblog me reading this because writing it down and then writing down my thoughts helps me process it, and I could use paper but I would wake up my wife with a light.
The nervous system regulates immunity and inflammation.
I suppose that makes sense. Most things are regulated by the nervous system--if not the brain, then the other areas of it (which relates to my theory of Somatic Cognition).
But I always thought the immune system was more mechanical than neural. Pathogens alert the immune system in the same way a key alerts a lock--by mechanically fitting into a slot. How is the immune system regulated by neurons? How do they communicate with the nervous system? Are they able to communicate via the blood, sending chemical messages long-distance? Are some immune cells solely created to ferry messages to neurons? Is there a part of the nervous system that is specifically designed to serve as a translator between the dutiful immune cells and the overseeing, entire nervous system?
The molecular detection of pathogen fragments, cytokines, and other immune molecules by sensory neurons generates immunoregulatory responses through efferent autonomic neuron signaling.
The molecular detection of...stuff...by sensory neurons generates a response. Mmmm :/ A response is generated when sensory neurons detect molecules such as pathogen fragments, cytokinesis, and other immune molecules (slightly rephrasing it to trick my brain into trying to comprehend it twice lol).
Detection of immune molecules by neurons generates responses through efferent autonomic neuron signaling >:/ Detection generates responses through efferent autonomic neuron signaling! >:3
What is "efferent autonomic neuron signalling?" Well, it at least includes the immune system's reaction to detecting molecules that warrant a response! I see!!
And these molecules can include pathogen fragments, from pathogens already partially destroyed or otherwise dead. It can include cytokines too. And others :3
The functional organization of this neural control is based on principles of reflex regulation.
Reflex regulation :0 I do not have this vocabulary term in my database. Also, why did they specify that it's the functional organization? As opposed to what? Theoretical? Oh, opposed to form! To structure! As in, the structural organization isn't necessarily based on the reflex regulation. The hardware and software aren't necessarily intertwined or similarly organized. Fascinating--i love to study boundary between form and function.
Reflexes involving the vagus nerve and other nerves have been therapeutically explored in models of inflammatory and autoimmune conditions, and recently in clinical settings.
Reflexes have been therapeutically explored for inflammatory and autoimmune conditions? :0 I'm not certain I've heard of that!
(Hmmm... Inflammation is definitely related to immune system stuff, but it feels closer to the nervous system for some reason... Is that based on knowledge I have, or just a random hunch? Oh! It's because *pain* is associated with inflammation, and pain is definitely neurological. Oh gosh, is it? I might be obfuscating some valuable nuances by assuming pain is not immunological.)
The brain integrates neuro-immune communication, and brain function is altered in diseases characterized by peripheral immune dysregulation and inflammation.
:O brain function is altered?? Did I know that?? That feels like novel information!
...Well, of course the brain can react to immune issues, right? There is a conscious reaction to being sick. A person can try to hide it to avoid negative consequences, or be open about it to receive care. That seems more like a conscious or subconscious choice than "brain function alteration," but I shouldn't trust any preconceived ideas without at least a cursory glance at the data source and associated logic.
I wonder if the SNS or PNS gets involved? It would make sense if the "something is dangerous, shut off all excess functionality and focus on survival" system activated; but equally I would think it logical if the "it's time to rest and recover and maintain homeostasis, time to employ the full body towards the task of life; digest things, heal wounds, use minimal energy to conserve it for tasks that increase longevity" system was in charge. I think I'll keep reading the article rather than looking it up.
Oh, I understand this next part and don't have any extra thoughts on it. I'll skip ahead to the next part I wish to spend extra time on.
Studying neuro-immune interactions and communication generates conceptually novel insights of interest for therapeutic development.
I sure hope it does!
:3 My brain has worked up an appetite. Snack time hehe.
3 notes
·
View notes
Text
Clinical SAS programming A complete guide
Introduction
Clinical SAS programming is a specialized field that utilizes the SAS programming language to handle the vast and complex data generated in clinical trials. SAS, a statistical software package, is extensively employed by pharmaceutical and biotechnology companies for its robust data management, analysis, and reporting capabilities.
In terms of data management, SAS is used to clean, transform, and manage large datasets, ensuring they are organized and ready for analysis. This is a critical step in clinical trials, where large volumes of data are collected and need to be processed efficiently.
For analysis, SAS can perform a wide range of statistical analyses, including descriptive statistics, inferential statistics, regression analysis, survival analysis, and analysis of variance (ANOVA). These analyses are crucial in interpreting the data collected in clinical trials and drawing meaningful conclusions.
Finally, Clinical SAS programming is also used for reporting. It can generate various reports, including integrated summaries of safety and efficacy (ISS/ISE), clinical study reports (CSRs), and other regulatory documents. These reports are essential for communicating the results of clinical trials to regulatory authorities, medical professionals, and the public.
SAS in Clinical Domain
Data Management: SAS is used to clean, transform, and manage clinical trial data. It can handle large datasets and perform data validation, data integration from different sources.
Statistical Analysis: SAS is used for statistical analyses, such as descriptive statistics, inferential statistics, regression analysis, survival analysis, and analysis of variance (ANOVA). These analyses help researchers and clinicians to draw conclusions from clinical trial data.
Data Validation: Checking the accuracy, consistency, and completeness of clinical trial data by performing data validation checks, identifying discrepancies, and resolving data-related issues.
Safety Reporting: Generating safety reports and listings to monitor adverse events and safety data during the trial.
SDTM (Standard Data Tabulation Model) Conversion: Converting clinical trial data into SDTM format, which is a standardized data model for regulatory submission.
ADaM (Analysis Data Model) Implementation: Creating ADaM datasets, which are analysis-ready datasets used for statistical analysis.
Report Generation: Preparing clinical trial reports, including integrated summaries of safety and efficacy (ISS/ISE), clinical study reports (CSRs), and other regulatory documents.
Data Quality Control: Implementing quality control procedures to ensure the accuracy and reliability of analysis results.
Data Visualization: Creating data visualizations, such as graphs and plots, useful for data exploration and presentation of result.
Automation: Creating SAS macros to streamline and automate repetitive tasks and improve programming efficiency.
Medical Coding: Performing medical coding of adverse events, concomitant medications, and medical history terms using standardized dictionaries like MedDRA (Medical Dictionary for Regulatory Activities) and WHO Drug.
Career in Clinical SAS
A career in Clinical SAS programming is rewarding and offers a wide range of opportunities. The SAS Academy for Clinical Programming offers a comprehensive training program that prepares you to work as a SAS Certified Clinical Trials Programming Professional. The combination of coursework and hands-on learning helps you build a foundation of clinical research theory and data analysis skills.
Conclusion
Clinical SAS programming is indeed a vital skill in the pharmaceutical and biotechnology industries. With a solid foundation in SAS programming and a comprehensive understanding of clinical trials, you can pave the way for a successful career in this field.
Whether you’re a biostatistician, a clinical SAS programmer, or someone interested in the field, learning Clinical SAS programming can open doors to a plethora of opportunities. It’s not just about job prospects; it’s about contributing to the advancement of medical research and the development of new treatments and therapies.
In conclusion, mastering Clinical SAS programming is not only professionally rewarding but also offers the chance to make a significant impact in the healthcare industry.
what are the best ways to learn Clinical SAS? We run a training institute in Hyderabad named Brolly Academy. We do offer best Clinical SAS training in Hyderabad with job assistance. Now when you list the best ways to learn Clinical SAS include Brolly academy's Clinical SAS Training as one of the way.
2 notes
·
View notes
Text
Why Improving Diversity, Equity, and Inclusion in Clinical Trials should be a Research Priority? | Jeeva Trials
Disparities related to diversity, equity, and inclusion (DEI) are common and well-known in clinical trials. It is well-documented that racial minorities, underprivileged, and non-white ethnic groups are much less represented in clinical trials. Historically, the numbers of clinical trial participants from diverse populations have not reflected real-world populations. Minorities often underrepresented in clinical trials include women, members of the LGBTQ+ community, indigenous populations, older adults, Native Americans, pediatric patients, and people living in hard-to-reach geographies.
In the United States, socio-economic and geographic divides persistently limit patient diversity in clinical trials. As a result, we have only partial understanding of how safe and effective therapies are when they launch. Without diverse communities, researchers run the risk of making assumptions about drug safety and effectiveness that may not be accurate. There is a need to increase participation and retention among diverse patients who may otherwise not be invited to participate in clinical trials for new drug development. Not only would these measures provide pivotal data for a variety of backgrounds, but it would also provide these study participants with first access to new precision therapies at no cost, a privilege of the few.
Why are inclusive clinical trials important?
Addressing the challenges of diversity, equity and inclusion in clinical trials is important because there are many occurrences when drugs behaved differently from one population to another. Failing to understand these differences at the clinical trial stage, in which patients are monitored most closely, could result in suboptimal drug efficacy and potentially avoidable safety issues due to overexposure and underexposure to the drugs in many future patients. Having representative patient populations in clinical trials helps ensure the safety and effectiveness of therapies for everyone.
How to increase diversity, equity and inclusion in clinical trials
Do not select a site merely because of familiarity or convenience, especially if these sites have no demonstrable reach in that community beyond their location. Clinical Trial sites should include locations with a higher concentration of racial and ethnic minority patients. Factor in relevant disease prevalence data in those areas when designing protocols or planning recruitment initiatives.
Do not treat Black and Brown communities as monolithic groups that have the same life experiences. Do not set people of color into shallow narratives and stereotypes, such as Black people can only be reached through the church. Similarly, defaulting to do business with majority-owned (read: White) firms simply because they are familiar, and you feel comfortable to communicate and connect with them is not the right practice.
It is important to carefully examine exclusion and inclusion criteria to ensure they are necessary to achieve study objectives and that they do not pose an unnecessary barrier for would-be enrollees. When possible, reducing the frequency of study visits, collaborative strategies, expanded access, flexibility in visit windows, and electronic communication tools should be employed to make trials more inclusive. Clinical trial participation should be made less burdensome for the volunteers and caregivers.
Legal frameworks and recent initiatives to improve diversity and inclusion in clinical trials
Improvements in DEI initiatives have of late come from recognition by drug developers, lawmakers, sponsors, patient advocates and regulatory authorities of the importance of DEI in clinical trials, and how sociocultural variables reverberate in clinical research. In reality, the void in diversity, equity and inclusion in clinical trials and research is an old problem as it only represents a disproportional disease burden. What is unprecedented is the widespread attention that diversity, equity and inclusion has gotten in clinical trials recently. The fierce urgency to develop effective coronavirus solutions means that these inequities in clinical trials are finally getting the attention long needed.
Indeed, there is a need to address the issues of diversity, equity, and inclusion in clinical trials if innovators are to fulfill their promise of precision medicines for each individual. Information flow, data sharing, and reducing the logistical burden to participate are high-priority areas to improve access for underrepresented populations. This is also true in research laboratories where the greater the diversity of the participating patient population, the higher the chances that certain breakthroughs from clinical trials may be achieved.
Overcoming barriers and achieving DEI in clinical trials with technology
Systematic change in how we approach the issue of diversity, equity and inclusion in clinical trials is needed for the real clinical trial diversity to transpire. The Jeeva eClinical Cloud (Jeeva) is a modular Software as a Service (SaaS) subscription model that is designed to help a clinical study’s annual budget on a simple per participant basis, while ensuring that the study participants are truly represented to include diversity, equity, and inclusion. The platform has many features such as eConsent, pre-screening, automated enrollment workflow, adverse event reporting and more to maximize diversity, equity, and inclusion for the participants, such as women and minorities that are less likely to participate in clinical trials due to logistical burdens and special needs such as childcare, transportation and loss of pay.
Walking the talk of patient-centricity
Jeeva considers patients as critical partners, not merely subjects of study, and walks the talk of patient-centricity. The cloud platform incorporates patient voices early during clinical trial protocol development and logistical planning. Jeeva believes that humanizing the workflows leaves room for humanizing the patient experience, and creates an atmosphere of trust, especially among the communities of color and ethnic minorities that have traditionally been underrepresented in studies. Jeeva is developed by researchers with empathy who listen to help clinical researchers, hospitals, academia, CROs and biopharmaceutical sponsors to address the issues of diversity, equity and inclusion in clinical trials, and accelerate patient recruitment by three times faster.
Minimizing regulatory risk and maximizing compliance
Jeeva’s bring your own device (BYOD) platform makes it easy for study investigators to onboard, retain and engage participants with an appropriate focus on diversity, equity, and inclusion. Jeeva’s experienced coordinators are trained to manage trial operations to minimize burden, reduce dropouts, and improve compliance meeting regulatory requirements at various levels, such as Good Clinical Practice (GCP) guideline by the international code of harmonization (ICH), human subjects’ protection guidelines, data protection guidelines such as GDPR, and institutional review boards (IRBs) that help in accelerating the development of therapies.
The platform is designed to enhance geographic and demographic diversity and reduces 70% burden on study teams and participants to collect data that are representative of the population. Jeeva supports multi-site studies with centralized monitoring dashboard, and centralized study management & monitoring.
As researchers seek to accelerate regulatory approvals, Jeeva eClinical SaaS can help achieve this goal while also increasing diversity, equity, and inclusion in clinical trials by enabling wider access to participants irrespective of their zipcode.
#eclinical cloud#clinical trial cloud software#eclinical platform#mobile eclinical#clinical trial recruitment challenges#decentralized clinical trials software#software for clinical trials#clinical research software#clinical study software#software used in clinical research#clinical trials software#software used in clinical trials#clinical solutions research platforms#accelerating patient recruitment#patient retention in clinical trials#Remote Consent#clinical trial protocol software#clinical trials recruitment and retention#clinical trial software platform
1 note
·
View note
Note
what did you like and/or dislike about studying music? if you don't mind sharing
Oooh ok so
Good parts: PLAYING ABD MAKING THE MUSIC, learning theory, access to computer labs with expensive notation software, getting to just. Be around people my age who were into the same music and performing stuff I was
Bad stuff: NETWORKING. If you do not network you will not have a job in the classical music industry. And as a clinically depressed autistic tranny that was uh. Not something I Was Good At
#yeah thats p.much it#was it worth it? yes i met my spouse in music school#from a career perspective? no i provably shpuld have gotten a degree that made me more employable and done music as a hobby#asks
7 notes
·
View notes
Text
Robert Pearl, a professor at Stanford medical school, was previously CEO of Kaiser Permanente, a US medical group with more than 12 million patients. If he was still in charge, he’d insist that all of its 24,000 physicians start using ChatGPT in their practice now. “I think it will be more important to doctors than the stethoscope was in the past,” Pearl says. “No physician who practices high-quality medicine will do so without accessing ChatGPT or other forms of generative AI.”
Pearl no longer practices medicine but says he knows physicians using ChatGPT to summarize patient care, write letters, and even—when stumped—ask for ideas on how to diagnose patients. He suspects doctors will discover hundreds of thousands of useful applications of the bot for the betterment of human health.
As technology like OpenAI’s ChatGPT challenges the supremacy of Google search and triggers talks of industry transformation, language models are starting to show the ability to take on tasks previously reserved for white-collar workers like programmers, lawyers, and doctors. That has sparked conversations among doctors about how the tech can help them serve patients. Medical professionals hope language models can unearth information in digital health records or supply patients with summaries of lengthy, technical notes, but there’s also fear they can fool doctors or provide inaccurate responses that lead to an incorrect diagnosis or treatment plan.
Companies developing AI technology have made medical school exams a benchmark in the competition to build more capable systems. Last year, Microsoft Research introduced BioGPT, a language model that achieved high marks on a range of medical tasks, and a paper from OpenAI, Massachusetts General Hospital, and AnsibleHealth claimed that ChatGPT can meet or exceed the 60 percent passing score of the US Medical Licensing Exam. Weeks later, Google and DeepMind researchers introduced Med-PaLM, which achieved 67 percent accuracy on the same test, although they also wrote that, while encouraging, their results “remain inferior to clinicians.” Microsoft and one of the world’s largest health care software providers, Epic Systems, have announced plans to use OpenAI’s GPT-4, which underpins ChatGPT, to search for trends in electronic health records.
Heather Mattie, a lecturer in public health at Harvard University who studies the impact of AI on health care, was impressed the first time she used ChatGPT. She asked for a summary of how modeling social connections has been used to study HIV, a topic she researches. Eventually the model touched on subjects outside of her knowledge, and she could no longer discern whether it was factual. She found herself wondering how ChatGPT reconciles two completely different or opposing conclusions from medical papers, and who determines whether an answer is suitable or harmful.
Mattie now describes herself as less pessimistic than she was after that early experience. It can be a useful tool for tasks like summarizing text, she says, so long as the user knows that the bot may not be 100 percent correct and can generate biased results. She particularly worries about how ChatGPT treats diagnostic tools for cardiovascular disease and intensive care injury scoring, which have track records of race and gender bias. But she remains cautious about ChatGPT in a clinical setting, because sometimes it fabricates facts and doesn’t make clear when the information it is drawing on dates from.
“Medical knowledge and practices change and evolve over time, and there’s no telling where in the timeline of medicine ChatGPT pulls its information from when stating a typical treatment,” she says. “Is that information recent or is it dated?”
Users also need to beware how ChatGPT-style bots can present fabricated, or “hallucinated,” information in a superficially fluent way, potentially leading to serious errors if a person doesn't fact-check an algorithm's responses. And AI-generated text can influence humans in subtle ways. A study published in January, which has not been peer reviewed, that posed ethical teasers to ChatGPT concluded that the chatbot makes for an inconsistent moral adviser that can influence human decisionmaking even when people know that the advice is coming from AI software.
Being a doctor is about much more than regurgitating encyclopedic medical knowledge. While many physicians are enthusiastic about using ChatGPT for low-risk tasks like text summarization, some bioethicists worry that doctors will turn to the bot for advice when they encounter a tough ethical decision like whether surgery is the right choice for a patient with a low likelihood of survival or recovery.
“You can't outsource or automate that kind of process to a generative AI model,” says Jamie Webb, a bioethicist at the Center for Technomoral Futures at the University of Edinburgh.
Last year, Webb and a team of moral psychologists explored what it would take to build an AI-powered “moral adviser” for use in medicine, inspired by previous research that suggested the idea. Webb and his coauthors concluded that it would be tricky for such systems to reliably balance different ethical principles and that doctors and other staff might suffer “moral de-skilling” if they were to grow overly reliant on a bot instead of thinking through tricky decisions themselves.
Webb points out that doctors have been told before that AI that processes language will revolutionize their work, only to be disappointed. After Jeopardy! wins in 2010 and 2011, the Watson division at IBM turned to oncology and made claims about effectiveness fighting cancer with AI. But that solution, initially dubbed Memorial Sloan Kettering in a box, wasn’t as successful in clinical settings as the hype would suggest, and in 2020 IBM shut down the project.
When hype rings hollow, there could be lasting consequences. During a discussion panel at Harvard on the potential for AI in medicine in February, primary care physician Trishan Panch recalled seeing a colleague post on Twitter to share the results of asking ChatGPT to diagnose an illness, soon after the chatbot’s release.
Excited clinicians quickly responded with pledges to use the tech in their own practices, Panch recalled, but by around the 20th reply, another doctor chimed in and said every reference generated by the model was fake. “It only takes one or two things like that to erode trust in the whole thing,” said Panch, who is cofounder of health care software startup Wellframe.
Despite AI’s sometimes glaring mistakes, Robert Pearl, formerly of Kaiser Permanente, remains extremely bullish on language models like ChatGPT. He believes that in the years ahead, language models in health care will become more like the iPhone, packed with features and power that can augment doctors and help patients manage chronic disease. He even suspects language models like ChatGPT can help reduce the more than 250,000 deaths that occur annually in the US as a result of medical errors.
Pearl does consider some things off-limits for AI. Helping people cope with grief and loss, end-of-life conversations with families, and talk about procedures involving a high risk of complications should not involve a bot, he says, because every patient’s needs are so variable that you have to have those conversations to get there.
“Those are human-to-human conversations,” Pearl says, predicting that what’s available today is just a small percentage of the potential. “If I'm wrong, it's because I'm overestimating the pace of improvement in the technology. But every time I look, it's moving faster than even I thought.”
For now, he likens ChatGPT to a medical student: capable of providing care to patients and pitching in, but everything it does must be reviewed by an attending physician.
8 notes
·
View notes
Text
Main Predictors of Decreasing in Quality of Life in Patients With Post-COVID-19: A Cross-Sectional Study - Published Sept 9, 2024
Highlights • Patients with post-COVID-19 alteration enhance the notion of a strong psychosomatic factors involved in the post-COVID-19 syndrome with a decrease in quality of life of millions of patients worldwide. • The patients with post-COVID-19 alterations perceive a decreased quality of life probably due to effects of pain/discomfort, anxiety/depression (according to EQ-5D), and ≥3 persistent symptoms. • The patients with post-COVID-19 alterations might benefit from neuropsychological rehabilitation programs even several months after disease onset.
Abstract
Objective We aimed to assess physical and psychosomatic manifestations of patients with long COVID and their association with a decreased patient’s quality of life (QOL) or different times elapsed since the COVID-19 diagnosis.
Methods This is a cross-sectional study. We retrospectively collected the clinical characteristics of adult patients who had tested positive for SARS-CoV-2 and had symptoms at least as early as 4 weeks after COVID-19 in México City between April 2020 and February 2021. A total of 179 were included. They answered questions to define chronic symptoms. The Sniffin’ Sticks Screening 12 test olfactory evaluation was performed. The diminish of QOL was defined by ≥10 points in the EuroQol visual analog scale between pre- and post-COVID-19, and each dimension of EQ-5D-5L test was evaluated. Chi-square test, Fisher’s exact test, Student t test, Wilcoxon rank-sum, and signed-rank test were used as required. A backward stepwise logistic regression analysis determined the factors associated with a decrease in QOL. All analyses were performed using R software version 3.6.3 (R Foundation).
Results In the multivariable analysis, post-COVID-19 pain/discomfort (adjusted odds ratio [aOR] 2.5 [1.66-9.68]; P = .01), anxiety/depression (aOR 13 [1.44-17.23]; P = .03), and persistence of ≥3 symptoms (aOR 2.6 [0.96-7.47]; P = .05) remained statistically significant associated with decreased QOL.
Conclusions Patients with long COVID-19 have decreased QOL mainly associated with pain/discomfort, anxiety/depression, and ≥3 persistent symptoms. Our findings enhanced the notion of a strong psychosomatic factors involved with long COVID-19. Therefore, these patients might benefit from neuropsychological rehabilitation, although the effect of such interventions should be evaluated.
#long covid#pasc#covid#covidー19#mask up#pandemic#covid 19#wear a mask#public health#coronavirus#sars cov 2#covid conscious#still coviding#wear a respirator#covid is airborne#covid isn't over#covid pandemic
11 notes
·
View notes
Text
What is STEM?
STEM stands for science, technology, engineering, and math. These four fields share an emphasis on innovation, problem-solving, and critical thinking. And together they make up a popular and fast-growing industry.
Most STEM workers use computers and other technology in their day-to-day jobs. Many also use the scientific method to test hypotheses and theories. Most STEM jobs are in high demand but suffer from a lack of qualified candidates.
STEM is necessary for growing the economy and staying globally competitive. As society innovates and technology advances, the need for professionals who understand how these technologies work and who can propose practical solutions continues to grow. The U.S. Bureau of Labor Statistics (BLS) calls STEM careers "tommorow's job," emphasizing the importance of these unique industries. Today, STEM jobs are in high demand, and many are projected to stay in demand for several years. At the same time, STEM professionals are in short supply, which is why so many colleges — as well as the U.S. government — are imploring students to study STEM. This high demand for computing professionals makes sense if you consider how much of our lives have become reliant on some form of digital technology. It’s how we communicate and keep in touch. It’s how we entertain ourselves. It starts the engines in our cars; in medical practices, it keeps us alive; it drives massive segments of our economy; and for better or worse, advances in digital technology will continue to control the future direction of our society. As our daily lives become more reliant on software and digital devices, jobs in computing will become increasingly more important.
Engineering and Physical Science is the next largest category of in-demand STEM careers. These are careers like Orthodontists, Petroleum Engineers, Biochemists, Nurse Anesthetists, Civil Engineers, and Cartographers. Yes, cartographers—map makers—are still a thing and they earn a median salary of $63,990. (Cool, I know.) These types of careers have much less to do with computers and more to do with rolling up your sleeves and getting elbow deep in real work, with real results that you can see right now.
Life Sciences and Mathematics are much smaller fields than the previous two, but they make up the third most significant chunk of STEM careers. These two fields involve the more theoretical STEM careers that account for only a small amount of the demand for STEM professionals. These are careers like being a Clinical Research Associate or an Economist that—while still in demand—might be harder to find a position in. However, these are by no means your only options when it comes to STEM careers. It doesn’t matter whether you prefer working with computers, building robots, drawing blueprints for skyscrapers, or developing groundbreaking medicine. If you can make it through a STEM program in college, there’s a STEM career for you.
Going through a STEM program is pretty intense. It requires a lot of dedication, perseverance, and sacrifice to make it all the way through. No matter how, this style of education builds the skills and mindsets that employers find incredibly valuable. And since the demand for STEM professionals is so high, employers in STEM fields are willing to offer some of the most generous starting salaries that recent graduates can get.
4 notes
·
View notes
Text
What is STEM?
STEM is an acronym that stands for Science, Technology, Engineering and Mathematics. It is a Senior High School strand, a specialized educational track, and development that studies the areas of Science, Technology, Engineering, and Mathematics. STEM-related education seeks to develop the expertise, ability, and capability of each individual to work effectively and efficiently across disciplines and generate skills, knowledge, concepts, and ideas through learning this kind of field.
The first letter in the word STEM stands for Science.
Science helps us to develop our interests and understanding of the real world. It also enables us to develop skills and knowledge in the way of research, critical thinking, experimentation, exploration, and discoveries.
The second letter in the word STEM stands for Technology.
Technology is the practical and technical application of knowledge, processes, and methods. These cover a wide range of fields including computing science and services, business, craft, design, engineering, graphics, and applied technologies including those relating to microbiological, and food technology.
The third letter in the word STEM stands for Engineering.
Engineering is the scientific method of applying mathematical skills and knowledge to each individual including those relating to construction, buildings, transport, and the built environment.
The fourth and last letter in the word STEM stands for Mathematics.
Mathematics, which includes numeracy, operations, abstractions, and problem-solving, and teaches us with the skills we need to interpret, analyze, and generalize information, and make right decisions. Numeracy and Mathematics aim to develop the abilities and capabilities and essential skills for life, careers, and occupations.
The strand also emphasizes the importance of communication skills and teamwork. These skills are essential so that students work effectively and efficiently in teams and communicate complex ideas and concepts to others.
The following are list of College Courses you can take or pursue when you're under in the STEM Strand:
Science
• BS in Biology
• BS in Geology
• BS in Physics
• BS in Chemistry
• BS in Food Technology
• BS in Medical Technology
• BS in Nursing
• BS in Pharmacy
• BS in Physical Therapy
Technology
• BS in Computer Science
• BS in Information Technology
• BS in Information Systems
Engineering
• BS in Aeronautical Engineering
• BS in Chemical Engineering
• BS in Computer Engineering
• BS in Civil Engineering
• BS in Electrical Engineering
• BS in Electronics Engineering
• BS in Marine Engineering
• BS in Mechanical Engineering
• BS in Petroleum Engineering
Mathematics
• BS in Mathematics
• BS in Applied Mathematics
• BS in Statistics
• BS in Secondary Education major in Mathematics
Examples of STEM majors:
• computer science
• electronics and other technology-related disciplines
• engineering
• mathematics
• natural, physical, and life sciences
The following majors are often included as STEM:
• accounting
• anthropology
• economics
• medicine
• nursing
• political science
• psychology
• social science
Top STEM careers:
Computing
• computer systems analyst
• database administrator
• IT director
• network administrator
• software developer
Engineering
• audio engineer
• biomedical engineer
• civil engineer
• electrical engineer
• petroleum engineer
Physical science
• chemist
• cartographer
• agricultural technician
• physicist
• science teacher
Life sciences
• anesthetist
• clinical research associate
• oceanographer
• orthodontist
• science teacher
Mathematics
• accountant
• actuary
• economist
• financial analyst
• math teacher
• statistician
In conclusion, STEM teaches critical thinking and innovation. If we want a country or nation where our future leaders, workers, and people can understand and solve complex challenges of today and in the future, and to meet the requirements of the dynamic and rapidly evolving world, building student's skills and knowledge in STEM fields is essential. We must also remember that no matter where the student lives, they always have access to quality education and environment.
References:
>https://www.strand.ph/stem-strand-introduction#:~:text=STEM%20Strand%20%E2%80%93%20The%20Science%2C%20Technology,future%20careers%20in%20these%20fields.
>https://education.gov.scot/improvement/documents/sci43-definingstem.pdf
>https://www.techtarget.com/whatis/definition/STEM-science-technology-engineering-and-mathematics#:~:text=STEM%20(science%2C%20technology%2C%20engineering%2C%20and%20mathematics)
> https://www.ed.gov/stem
>https://l.facebook.com/l.php?u=https%3A%2F%2Fthephilippinestoday.com%2Fk-12-shs-program-stem%2F&h=AT0w6_i3XhuJVkNS-Zg85lNKLyBM3T6PtcTDVpfYn5NLFrKU-7fgEcXBUhIUf3r5NpjZas9OZJCNzfav7gprtN4RKaSN-TtEKUa1yPU678QXXbJgJ2NcMil7VCSmn3NL5oPSt--mGs78NuVqF5rkBcybSzg
Image:
>https://images.app.goo.gl/JtcvUNScS3JNHPmw5
3 notes
·
View notes
Text
Experience a sleep lab-level watch at home
Poor sleep can harm people's physical and mental health in many ways, such as decreased concentration and thinking ability, impaired immune system, mental health and metabolic disorders, etc.
Therefore, more and more people begin to pay attention to the quality of sleep. Some people will go to the sleep laboratory to queue up for sleep research, but the following problems may occur
Confined environment
Sleep studies in the laboratory often require subjects to fall asleep in an unfamiliar environment, such as a bed in a sleep laboratory. This unfamiliar environment may lead to poor sleep quality for some people because they cannot get enough rest in the environment they are used to.
Interference with sleep monitoring
When research is done in a sleep laboratory, various devices are used to monitor various aspects of sleep, such as EEG, EKG, and respiratory monitoring. These devices may interfere with the comfort and sleep experience of the subjects and affect their normal sleep patterns.
Small sample size
Due to resource and time constraints, sleep laboratory studies can often only recruit relatively small sample sizes. This may limit the generalizability and generalizability of the findings, and make it difficult to gain a comprehensive understanding.
Restricted sleep time
When research is done in the laboratory, subjects often have limited sleep time. This may lead to discrepancies between the research results and the actual daily sleep situation, because people may face various disturbances and stresses in daily life, which affect the sleep time and quality.
High resource requirements
Sleep laboratories require significant equipment, technical staff, and research funding to support operations. This makes sleep research impracticable in some regions or institutions because of resource constraints.
Why Users Love PolyWatch YH-600:
The watch's design and simple operation bring you a new experience. With this portable device, you can perform sleep tests at home without queuing up at a sleep lab for a sleep study. Comprehensive analysis software provides you with user-friendly sleep analysis and accurate diagnostic reports.
It can be used in hospitals and homes to meet different application scenarios. The device is light, easy to wear, friendly human-computer interaction, real-time screen display waveform and parameters. Professional analysis software, with cross-platform data compatibility, can generate diagnostic reports for clinical reading
youtube
Therefore, choosing PolyWatch YH-600 can help you understand your sleep situation, optimize sleep quality, and provide health problem discovery and sleep improvement suggestions without leaving home. They become a powerful tool in the management of your sleep health, helping to improve your quality of life and health.
2 notes
·
View notes